Previous evidence suggested the potential anti-cancer activity of luteolin and apigenin by downregulating the AR and AKT signaling in PCa cells (Gupta et al., 2002; Chiu and Lin, 2008; Kaur et al., 2008; Shukla et al., 2014). This evidence concerns the gene AR and cancer.